The role of saposin C in Gaucher disease
- 31 July 2012
- journal article
- review article
- Published by Elsevier BV in Molecular Genetics and Metabolism
- Vol. 106 (3), 257-263
- https://doi.org/10.1016/j.ymgme.2012.04.024
Abstract
No abstract availableKeywords
Funding Information
- National Human Genome Research Institute and National Institutes of Health
This publication has 96 references indexed in Scilit:
- Saposins utilize two strategies for lipid transfer and CD1 antigen presentationProceedings of the National Academy of Sciences of the United States of America, 2012
- A mutation in SCARB2 is a modifier in gaucher diseaseHuman Mutation, 2011
- Molecular chaperones in protein folding and proteostasisNature, 2011
- X-ray and Biochemical Analysis of N370S Mutant Human Acid β-GlucosidaseOnline Journal of Public Health Informatics, 2011
- Molecular Basis of Reduced Glucosylceramidase Activity in the Most Common Gaucher Disease Mutant, N370SOnline Journal of Public Health Informatics, 2010
- Specific saposin C deficiency: CNS impairment and acid -glucosidase effects in the mouseHuman Molecular Genetics, 2009
- Multicenter Analysis of Glucocerebrosidase Mutations in Parkinson's DiseaseThe New England Journal of Medicine, 2009
- Prosaposin deficiency and saposin B deficiency (activator‐deficient metachromatic leukodystrophy): Report on two patients detected by analysis of urinary sphingolipids and carrying novel PSAP gene mutationsAmerican Journal of Medical Genetics Part A, 2009
- Molecular imaging of membrane interfaces reveals mode of β-glucosidase activation by saposin CProceedings of the National Academy of Sciences of the United States of America, 2007
- The iminosugar isofagomine increases the activity of N370S mutant acid β-glucosidase in Gaucher fibroblasts by several mechanismsProceedings of the National Academy of Sciences of the United States of America, 2006